CompletedNot Applicable

Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients

Iceland120 participantsStarted 2017-09-12

Plain-language summary

This study is done to evaluate the effects of Mindfulness Based Cognitive Therapy (MBCT) for primary care patients that have mild to moderate symptoms of depression and anxiety. Half of the study participants will receive treatment as usual (TAU), and the other half will receive TAU plus MBCT. The investigators will be comparing changes in symptoms of depression and anxiety between the groups, and hypothesize that the TAU plus MBCT group will have significantly lower symptoms of depression and anxiety compared to TAU group post-intervention

Who can participate

Age range18 Years – 67 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Age: \<18 and \>67 years old.
✕. Severe psychiatric symptoms requiring psychiatric care
✕. Risk of suicide
✕. Inability to participate in group sessions because of severe substance misuse;
✕. Inability to speak and understand Icelandic
✕. Pregnancy;
✕. Current psychotherapy of any kind;
✕. Participation in any other psychiatric intervention study;

What they're measuring

Symptoms of depression measured with the PHQ-9 questionnaire

Timeframe: up to 18 months

Symptoms of anxiety measured with the GAD-7 questionnaire

Timeframe: up to 18 months

Trial details

NCT IDNCT03272516

SponsorUniversity of Iceland

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-11-10

View on ClinicalTrials.gov More Depression, Anxiety trials